| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/09/2000 | US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle |
| 05/09/2000 | US6060456 Chimeric oligonucleoside compounds |
| 05/09/2000 | US6060455 Cationic and polycationic amphiphiles, reactives containing the same and their use |
| 05/09/2000 | US6060303 Use in screening assays and as pharmaceuticals. |
| 05/09/2000 | US6060294 Alanyl tRNA synthetase from Staphylococcus aureus |
| 05/09/2000 | US6060275 Sprouty protein and coding sequence |
| 05/09/2000 | US6060270 Central lumen bordered by polarized epithelium and produced by culturing in all-trans retinoic acid, transforming growth factor-beta-1 and either epidermal growth factor or transforming growth factor-alpha; for kidney disorders |
| 05/09/2000 | US6060247 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 05/09/2000 | US6060239 Cellubrevin homologs |
| 05/09/2000 | US6060238 Method and composition for regulating apoptosis |
| 05/09/2000 | US6060082 Phospholipid bilayer having covalently bonded phospholipids, an aqueous core and a lectin wherein the lectin is ulex europeans agglutinin i. |
| 05/09/2000 | US6060081 Transporter is one or more di-c10-20 alkylamide glycylspermines. |
| 05/09/2000 | US6060052 Expanding primitive stem cells for restoration of hematopoietic capabilities and for providing modified human stem cells for gene therapy applications; transplantation of human hematopoietic stem cells |
| 05/09/2000 | US6060048 Method for transplanting cells into the brain and therapeutic uses therefor |
| 05/09/2000 | US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety |
| 05/04/2000 | WO2000025138A2 Methods of diagnosing or prognosing alzheimer's disease |
| 05/04/2000 | WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 05/04/2000 | WO2000024917A1 Targeted gene modification by parvoviral vectors |
| 05/04/2000 | WO2000024913A2 Mn gene and protein |
| 05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
| 05/04/2000 | WO2000024896A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 05/04/2000 | WO2000024895A2 Method and model for hair pigmentation |
| 05/04/2000 | WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 05/04/2000 | WO2000024886A1 Prv-1 gene and the use thereof |
| 05/04/2000 | WO2000024885A2 p53 MORPHOLINO-BASED ANTISENSE |
| 05/04/2000 | WO2000024876A2 Spumavirus isolated from humans |
| 05/04/2000 | WO2000024780A2 Compositions and methods for treating polycystic kidney disease |
| 05/04/2000 | WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 05/04/2000 | WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000024759A1 Systemic delivery of gene products via skin |
| 05/04/2000 | WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
| 05/04/2000 | WO2000024755A1 Ovary-specific genes and proteins |
| 05/04/2000 | WO2000024754A1 infB POLYPEPTIDE AND POLYNUCLEOTIDES OF STREPTOCOCCUS PNEUMONIAE |
| 05/04/2000 | WO2000024427A1 Remedies for rheumatism containing fadd gene as the active ingredient |
| 05/04/2000 | WO2000024415A2 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 05/04/2000 | WO2000024412A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 05/04/2000 | WO2000024408A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 05/04/2000 | WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway |
| 05/04/2000 | WO2000024359A2 Use of gndf for treating retinal degeneration |
| 05/04/2000 | WO2000024254A1 Compositions and methods for modulating expression within smooth muscle cells |
| 05/04/2000 | WO2000014255A8 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES |
| 05/04/2000 | WO2000012741A3 Inducible expression system |
| 05/04/2000 | WO2000012139B1 Hypoxia regulated genes |
| 05/04/2000 | WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | WO2000006727A3 Human epidermal proteins hepi-1 to hepi-6 |
| 05/04/2000 | WO2000006705A3 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 05/04/2000 | WO2000006204A3 Genetically engineered cells and tissues |
| 05/04/2000 | WO2000006187A3 Modulation of apoptosis |
| 05/04/2000 | WO2000004876A8 Controlled release of bioactive substances |
| 05/04/2000 | WO2000002909A3 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 05/04/2000 | WO2000002897B1 Delta cleavage products and methods based thereon |
| 05/04/2000 | WO1999066959A3 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 05/04/2000 | WO1999066036A9 Transplants for myocardial scars |
| 05/04/2000 | WO1999062315A3 Method for altering the activity of proteins of the pka signaling pathway |
| 05/04/2000 | WO1999061066A3 Convection-enhanced delivery of aav vectors |
| 05/04/2000 | WO1999060146A9 Adeno-associated virus vectors and uses thereof |
| 05/04/2000 | WO1999053021A9 Cell differentiation/proliferation and maintenance factor and uses thereof |
| 05/04/2000 | WO1999047660A9 Retroviral packaging cell line |
| 05/04/2000 | DE19849643A1 An das AAV-Kapsid bindender, den Zelltropismus verändernder Antikörper und Verfahren zum gerichteten Gentransfer At the AAV capsid binding, cell tropism changing antibodies and methods for directed gene transfer |
| 05/04/2000 | DE19835910C1 Gen isoliert auf dem kurzen Arm des menschlichen Chromosoms 17 Gene isolated on the short arm of human chromosome 17 |
| 05/04/2000 | CA2349211A1 Prv-1 gene and the use thereof |
| 05/04/2000 | CA2348835A1 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 05/04/2000 | CA2348827A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | CA2348778A1 Targeted gene modification by parvoviral vectors |
| 05/04/2000 | CA2348634A1 Methods for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 05/04/2000 | CA2348563A1 Compositions and methods for treating polycystic kidney disease |
| 05/04/2000 | CA2348529A1 Conductance of improperly folded proteins through the secretory pathway |
| 05/04/2000 | CA2348430A1 Ovary-specific genes and proteins |
| 05/04/2000 | CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 05/04/2000 | CA2347294A1 Novel g protein coupled receptor protein, dna and its ligand |
| 05/04/2000 | CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 05/04/2000 | CA2344207A1 Biological material for preparing pharmaceutical compositions for treating mammals |
| 05/03/2000 | EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof |
| 05/03/2000 | EP0997477A2 MHC complexes and uses thereof |
| 05/03/2000 | EP0996857A2 Cancer associated nucleic acids and polypeptides |
| 05/03/2000 | EP0996739A2 Improvments in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
| 05/03/2000 | EP0996738A1 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
| 05/03/2000 | EP0996737A1 Semliki forest virus vectors for gene transfer into non-endothelial cardiovascular cells |
| 05/03/2000 | EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 05/03/2000 | EP0996730A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
| 05/03/2000 | EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 05/03/2000 | EP0996725A1 Human nk-3 related prostate specific gene-1 |
| 05/03/2000 | EP0996721A2 Secreted proteins and polynucleotides encoding them |
| 05/03/2000 | EP0996720A2 Use of pea3 in tumor suppression |
| 05/03/2000 | EP0996719A1 A novel nucleic acid molecule |
| 05/03/2000 | EP0996716A1 Zggbp1,novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 05/03/2000 | EP0996635A1 Novel family of pheromone receptors |
| 05/03/2000 | EP0996632A1 Angiostatin fragments and method of use |
| 05/03/2000 | EP0996628A2 Mammalian neuro-growth factor like protein |
| 05/03/2000 | EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6 |
| 05/03/2000 | EP0996337A1 A process of delivering a polynucleotide via the vascular system |
| 05/03/2000 | EP0862419B1 Microencapsulated dna for vaccination and gene therapy |
| 05/03/2000 | EP0812204A4 Codominance-mediated toxins |
| 05/03/2000 | EP0669977B1 Transformed endothelial cells |
| 05/03/2000 | EP0624100B1 Dna encoding a human serotonin receptor (5-ht 4b) and uses thereof |
| 05/03/2000 | EP0559884B1 Viral recombinant vectors for expression in muscle cells |
| 05/03/2000 | EP0460042B1 Vector for integration site independent gene expression in mammalian host cells |
| 05/03/2000 | EP0383803B1 Oligonucleotide-polyamide conjugates |
| 05/03/2000 | CN1252075A Synthetic HIV GAG genes |
| 05/03/2000 | CN1252006A Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |